In our earlier studies, we discovered that a new form of FANCL protein, named FAVL, dysregulates the FA signaling in non-FA human tumor cells and acts as a tumor promoting factor by inactivating FANCD2 and FANCI/the ID complex [79,80,81,82]. The gene discussed is FANCD2; the disease is Friedreich ataxia.